KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
Brandon M. Brown(University of California, Davis), Heike Wulff(University of California, Davis)
Cited by 48
Related Papers
Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia
|Glia|2016|171
Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
|Annals of Clinical and Translational Neurology|2017|72